Stephens Inc’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,665
| Closed | -$235K | – | 1325 |
|
|
2021
Q4 | $235K | Sell |
2,665
-527
| -17% | -$46.5K | ﹤0.01% | 1142 |
|
|
2021
Q3 | $247K | Sell |
3,192
-409
| -11% | -$31.6K | ﹤0.01% | 1127 |
|
|
2021
Q2 | $300K | Buy |
3,601
+296
| +9% | +$24.7K | ﹤0.01% | 1034 |
|
|
2021
Q1 | $250K | Sell |
3,305
-849
| -20% | -$64.2K | ﹤0.01% | 1077 |
|
|
2020
Q4 | $364K | Sell |
4,154
-234
| -5% | -$20.5K | 0.01% | 862 |
|
|
2020
Q3 | $334K | Buy |
4,388
+159
| +4% | +$12.1K | 0.01% | 840 |
|
|
2020
Q2 | $522K | Sell |
4,229
-697
| -14% | -$86K | 0.01% | 686 |
|
|
2020
Q1 | $416K | Sell |
4,926
-56
| -1% | -$4.73K | 0.01% | 694 |
|
|
2019
Q4 | $421K | Buy |
4,982
+832
| +20% | +$70.3K | 0.01% | 774 |
|
|
2019
Q3 | $280K | Sell |
4,150
-90
| -2% | -$6.07K | 0.01% | 935 |
|
|
2019
Q2 | $363K | Buy |
4,240
+966
| +30% | +$82.7K | 0.01% | 846 |
|
|
2019
Q1 | $291K | Sell |
3,274
-166
| -5% | -$14.8K | 0.01% | 927 |
|
|
2018
Q4 | $293K | Buy |
3,440
+296
| +9% | +$25.2K | 0.01% | 857 |
|
|
2018
Q3 | $305K | Buy |
+3,144
| New | +$305K | 0.01% | 924 |
|